Liver Preservation Systems Market: By Preservation Technique, Static Cold Storage, Others), By Preservation Solution Solution, Human Biosystem Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User, and Region Forecast 2019-2030  

Liver Preservation Systems Market Size, Share, Growth, Trends, and Global Industry Analysis: By Preservation Technique (Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others), By Preservation Solution (Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution, Human Biosystem (HBS) Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User (Hospitals, Clinics, Others), and Region Forecast 2019-2030  

Liver Preservation Systems Market size was valued at US$ 174.2 million in 2023 expected to reach a value of US$ 1,949.5 million by 2030, growing at a CAGR of 41.2% from 2024-2030. Liver Preservation Systems is defined as the kind of technique that is used for recognizing numerous preservation solutions found in poultry. The method includes chickens, ducks, waterfowl, turkeys, and other birds. Several preservation solutions are seen in birds, such as Avian Mycoplasmosis, Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, and others. A liver transplant, also called a hepatic transplant, can assist to save a person's life when the liver no longer functions. A doctor may counsel a liver transplant for an individual with end-stage liver illness. The rising prevalence of liver diseases and rising liver transplants as well as numerous products launched by the global market players. Liver preservation is the procedure of maintaining and protecting the donor liver from the liver gaining up to the establishment in the anticipated recipients. Oxygenation, Temperature, and other appropriate storage condition are to be kept to avoid liver injury throughout the preservation time, and liver works after the transplantation to recipients. The liver can be preserved in the preservation solution which is temperature-cooled to slow down the procedure of liver worsening from normal metabolic procedure. Liver procurement is typically achieved after the cardiac biomarkers death or brain death of the patients.

The global market provides a detailed overview of the and that can be segmented by preservation technique, by preservation solution, and by End user. By preservation technique, the market growth has been segmented into Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others. The Static Cold Storage (SCS) segment is likely to be the significant growing segment in terms of preservation technique. Based on Preservation solution, the market is segmented into Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution, Human Biosystem (HBS) Solution, Renograf, Viaspen, Lifor, Perfadex, and Others. Among these, the Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution preservation solution segment is expected to have the significant growing market during the forecast period 2022-2028. Based on the End user, the Liver Preservation Systems market is segmented into Hospitals, Clinics, Others.

Liver Preservation Systems Market Key Developments

  • In November 2021, Paragonix Technologies introduced the LIVERguard Donor Liver Preservation System in Europe and United States.
  • In September 2021, TransMedics Group, Inc. announced the premarketing approval by the U.S FDA of its OCS Liver System for usage with organs from donors who expired after circulatory death (DCD) or after brain death (DBD).

Global Liver Preservation Systems Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

41.2%

Largest Market

North America

Fastest Growing Market

North America

Liver Preservation Systems Market Dynamics

The rising geriatric population is anticipated to propel the market growth over the forecast years. Moreover, the growth in cases of liver failure is burgeoning the market growth over the forecast years.

Global Liver Preservation Systems Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 174.2 million

Market Size in 2030

US$ 1,949.5 million

Market CAGR

41.2%

By Preservation Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others

By Preservation solution

  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
  • Human Biosystem (HBS) Solution
  • Renograf
  • Viaspen
  • Lifor
  • Perfadex
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

Key Features of the Report

  • The liver preservation systems market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

Liver preservation systems market size was valued at US$ 174.2 million in 2023 and is set to reach US$ 1,949.5 million growing at a CAGR of 41.2%.

The key players of liver preservation systems market are Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Waters Medical Systems LLC (U.S.), Essential, Pharmaceuticals LLC (U.S.), Xvivo Perfusion AB (Sweden), BioLife Solutions, Inc. (U.S.), Preservation Solutions, Inc. (U.S.), Transmedics, Inc. (U.S.), CryoLife, Inc. (U.S.)

North America is the fastest growing region.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Liver Preservation Systems Market Introduction 
2.1.Global Liver Preservation Systems Market  - Taxonomy
2.2.Global Liver Preservation Systems Market  - Definitions
2.2.1.Preservation  Technique
2.2.2.Preservation solution
2.2.3.End User
2.2.4.Region
3.Global Liver Preservation Systems Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Liver Preservation Systems Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Liver Preservation Systems Market  By Preservation  Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Hypothermic Perfusion Preservation (HPP)
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Static Cold Storage (SCS)
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Liver Preservation Systems Market  By Preservation solution, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Human Biosystem (HBS) Solution
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Renograf
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Viaspen
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Lifor
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Perfadex
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Liver Preservation Systems Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Liver Preservation Systems Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Preservation  Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hypothermic Perfusion Preservation (HPP)
9.1.2.Static Cold Storage (SCS)
9.1.3.Others
9.2.  Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
9.2.2.Human Biosystem (HBS) Solution
9.2.3.Renograf
9.2.4.Viaspen
9.2.5.Lifor
9.2.6.Perfadex
9.2.7.Others
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Preservation  Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hypothermic Perfusion Preservation (HPP)
10.1.2.Static Cold Storage (SCS)
10.1.3.Others
10.2.  Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
10.2.2.Human Biosystem (HBS) Solution
10.2.3.Renograf
10.2.4.Viaspen
10.2.5.Lifor
10.2.6.Perfadex
10.2.7.Others
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Preservation  Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hypothermic Perfusion Preservation (HPP)
11.1.2.Static Cold Storage (SCS)
11.1.3.Others
11.2.  Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
11.2.2.Human Biosystem (HBS) Solution
11.2.3.Renograf
11.2.4.Viaspen
11.2.5.Lifor
11.2.6.Perfadex
11.2.7.Others
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Preservation  Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hypothermic Perfusion Preservation (HPP)
12.1.2.Static Cold Storage (SCS)
12.1.3.Others
12.2.  Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
12.2.2.Human Biosystem (HBS) Solution
12.2.3.Renograf
12.2.4.Viaspen
12.2.5.Lifor
12.2.6.Perfadex
12.2.7.Others
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Preservation  Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Hypothermic Perfusion Preservation (HPP)
13.1.2.Static Cold Storage (SCS)
13.1.3.Others
13.2.  Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
13.2.2.Human Biosystem (HBS) Solution
13.2.3.Renograf
13.2.4.Viaspen
13.2.5.Lifor
13.2.6.Perfadex
13.2.7.Others
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Franz Kohler Chemie GmbH (Germany)
14.2.2.Organ Recovery Systems (U.S.)
14.2.3.Waters Medical Systems LLC (U.S.)
14.2.4.Essential Pharmaceuticals LLC (U.S.)
14.2.5.Xvivo Perfusion AB (Sweden)
14.2.6.BioLife Solutions, Inc. (U.S.)
14.2.7.Preservation Solutions, Inc. (U.S.)
14.2.8.Transmedics, Inc. (U.S.)
14.2.9.CryoLife, Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Franz Kohler Chemie GmbH (Germany)
  • Organ Recovery Systems (U.S.)
  • Waters Medical Systems LLC (U.S.)
  • Essential Pharmaceuticals LLC (U.S.)
  • Xvivo Perfusion AB (Sweden)
  • BioLife Solutions, Inc. (U.S.)
  • Preservation Solutions, Inc. (U.S.)
  • Transmedics, Inc. (U.S.)
  • CryoLife, Inc. (U.S.)

Related Industry Reports